🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — anyone have experience?

Pancreatitis risk assessment — anyone have experience?

JenPlateau Wed, Jul 2, 2025 at 6:56 PM 29 replies 1,958 viewsPage 1 of 6
This thread is more than 11 months old. Information may be outdated. Consider searching for more recent discussions.
JenPlateau
Member
234
890
Nov 2024
Missouri
Jul 2, 2025 at 6:56 PM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

Pooled safety analyses have not shown a clear excess of pancreatitis for this class, and the background rate in the population being treated is already elevated by obesity, gallstones and alcohol. That said, the labels carry the warning, and the presentation is distinctive enough to act on: severe persistent upper-abdominal pain radiating to the back, usually with vomiting, not relieved by anything.

Where I think it is weakest: the subgroup findings are the part I trust least — with enough subgroups something is always significant, and these were not all pre-registered.

The narrow version of the question is what the pooled safety data actually shows for this class, as opposed to what the label warning implies. I would rather have one careful answer than five confident ones.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
13 8HPLC_Greg, LibrarianMeg, bri_stats and 10 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jul 2, 2025 at 8:08 PM#2
JenPlateau said:
Pooled safety analyses have not shown a clear excess of pancreatitis for this class, and the background rate in the population being treated is…

Lipase monitoring while on pancreatitis risk: my doctor checks lipase every 3 months given the theoretical pancreatitis risk. All readings have been normal:

  • Baseline: 46 U/L
  • Month 3: 41 U/L
  • Month 6: 29 U/L
  • Month 9: 43 U/L

Normal range is 0-160 U/L. While clinical pancreatitis is rare (<0.5%), I find peace of mind in regular monitoring. Worth asking your doctor about if you're on a GLP-1 long-term.

12 7HPLC_Greg, LibrarianMeg, bri_stats and 9 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jul 2, 2025 at 9:20 PM#3
JenPlateau said:
Pooled safety analyses have not shown a clear excess of pancreatitis for this class, and the background rate in the population being treated is…

Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 8. Went to the ER — they checked lipase and amylase, both normal. Turned out to be a muscle strain.

But I'm glad I went. The risk of pancreatitis, while small (<0.5%), is real. Don't try to tough out severe abdominal pain on a GLP-1 agonist. Get checked.

11 6LondonLisa, mike_nyc, VendorMark and 8 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jul 2, 2025 at 10:32 PM#4

Answering the narrow version, because the broad one does not have a single answer. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

I would rather be corrected than agreed with, if it comes to it.

10 5Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 7 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jul 3, 2025 at 5:27 AM#5
labquiet_amy said:
Lipase monitoring while on pancreatitis risk: my doctor checks lipase every 3 months given the theoretical pancreatitis risk.

Mine went the same way, slower. I had assumed I was the exception until I read this.

9 4Dr.DermMIA, fiona_VT, denise_HTX and 6 others
Reply Quote Save Share Report
1236

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register